Skip to content
Study details
Enrolling now

Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea

University of California, Los Angeles
NCT IDNCT00695214ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

800

Study length

about 26 years

Ages

18+

Locations

1 site in CA

What this study is about

Researchers are testing a drug called propofol to help evaluate the upper airway in people with obstructive sleep apnea. The goal is to see if this technique, called drug-induced sleep endoscopy (DISE), can be used to reliably assess the upper airway. The trial will also compare DISE findings to other methods and look at how DISE results relate to surgical outcomes.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Propofol sedation

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Injection / IV

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

general anesthetic (Facilitates GABA; induces unconsciousness)

Drug routes

injection (Injection)